Rheumatic Disease Clinical Trial
Official title:
Study of the Natural History, Pathogenesis and Outcome of Melorheostosis - a Rare Osteosclerotic Disease
Background: - The rare disease melorheostosis causes bones to thicken. This may lead to pain, and can affect bones, joints, and muscles. Researchers want to learn more about the disease and how it progresses. Objective: -To see what happens to people with melorheostosis over time and understand the causes of the disease. Eligibility: - People 18 and over with melorheostosis. - Their unaffected relatives. Design: - All participants will have a medical history and physical exam. - Participants who are relatives will give samples of blood or cheek cells. - Other participants will be in the study for about 1 week. - They will have blood and urine collected. - Strength, walking, and range of motion will be measured. - Participants may also have - X-rays and scans. - A pain and neurological evaluation. - Their skin evaluated by a dermatologist. - A small sample of bone taken. - Nerve conduction studies. Small electrodes with to wires will be put on the skin. A metal probe will give a small electrical shock. - Electromyography. A thin needle will be placed into the muscles. - An ultrasound, which uses sound waves to examine the muscles and nerves. An ultrasound probe will be placed over the skin. - A bone scan. They will get a small amount of radioactive fluid through a needle in an arm vein. This fluid travels to the bones. The bones will be photographed in a machine. - Bone Densitometry, a low-level x-ray. - Photographs taken. - A small circle of skin removed with a surgical instrument. - Questionnaires about their quality of life. - Participants will be asked to return about every 2 years. At these visits, participants may have blood and urine tests and x-rays.
Status | Recruiting |
Enrollment | 350 |
Est. completion date | July 15, 2025 |
Est. primary completion date | July 15, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | - INCLUSION CRITERIA: All eligible patients are invited to participate in this protocol. Patients are adults aged > 18 years with possible melorheostosis (suspected or confirmed). Since both men and women are affected with the disease, both sexes will be studied. All ethnic and racial groups are at risk and will be included. Relatives of patients with melorheostosis may be included for genetic testing only. EXCLUSION CRITERIA: - Pregnant or lactating women. A pregnancy test is performed in women of childbearing potential (up to age 55) unless they have a history of hysterectomy or tubal ligation. - Children (age less than 18 years) are excluded. - Subjects with severe active infection or other co-morbidities that in the opinion of the investigator would warrant exclusion. - Subjects unable to provide informed consent. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
United States,
Faruqi T, Dhawan N, Bahl J, Gupta V, Vohra S, Tu K, Abdelmagid SM. Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders. Biomed Res Int. 2014;2014:670842. doi: 10.1155/2014/670842. Epub 2014 Oct 22. — View Citation
Ihde LL, Forrester DM, Gottsegen CJ, Masih S, Patel DB, Vachon LA, White EA, Matcuk GR Jr. Sclerosing bone dysplasias: review and differentiation from other causes of osteosclerosis. Radiographics. 2011 Nov-Dec;31(7):1865-82. doi: 10.1148/rg.317115093. — View Citation
Jain VK, Arya RK, Bharadwaj M, Kumar S. Melorheostosis: clinicopathological features, diagnosis, and management. Orthopedics. 2009 Jul;32(7):512. doi: 10.3928/01477447-20090527-20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Disease progression | explore etiology and natural history of melorheostosis. Besides MAP2K1, what other genetic changes play a role in the etiology of melorheostosis. Does the disease progress to involve new bones or extend into soft tissues over time or is it static | end of the study | |
Secondary | Identify medication that affect melorheostosis | What medications are most effective to help with pain management in melorheostosis | end of the study | |
Secondary | Identify biomarkers | Can biomarkers of disease activity be ascertained. | end of the study |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01755832 -
Heated Pool Exercise Groups for Patients With Rheumatic Diseases
|
N/A | |
Completed |
NCT04704349 -
Latest Imaging SPECT System Evaluation Phase 1
|
N/A | |
Completed |
NCT01022905 -
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
|
Phase 4 | |
Completed |
NCT00377364 -
Acetaminophen (Tylenol) for Mood and Memory Changes Associated With Corticosteroid Therapy
|
Phase 4 | |
Completed |
NCT04616118 -
Comparing Modes of Telehealth Delivery: Phone vs. Video Visits (ASSIST)
|
N/A | |
Recruiting |
NCT00244153 -
Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00346710 -
Patient Experiences in Rheumatology
|
N/A | |
Not yet recruiting |
NCT05465356 -
Patient Engagement With Digital Health Tools in Rheumatology
|
||
Completed |
NCT00847236 -
Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
|
N/A | |
Recruiting |
NCT05191368 -
Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases
|
||
Completed |
NCT04754698 -
COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS
|
Phase 4 | |
Completed |
NCT03454438 -
Strategies to Improve Appropriate Referral to Rheumatologists
|
N/A | |
Terminated |
NCT03186794 -
Aerobic Exercise in Women With Systemic Lupus Erythematosus
|
N/A | |
Active, not recruiting |
NCT05283096 -
Survey About Diet in Chronic Inflammatory Rheumatic Diseases
|
||
Completed |
NCT05321901 -
Telerehabilitation in Women With Rheumatic Disease
|
N/A | |
Recruiting |
NCT01685905 -
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
|
N/A | |
Recruiting |
NCT06004349 -
Autoimmune and Autoinflammatory Genetics Study
|